Connection

Birgit Weynand to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Birgit Weynand has written about Drug Evaluation, Preclinical.
Birgit Weynand
Connection Strength
0.046
Drug Evaluation, Preclinical
  1. Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial. EBioMedicine. 2021 Apr; 66:103288.
    View in: PubMed
    Score: 0.024
  2. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. Proc Natl Acad Sci U S A. 2020 10 27; 117(43):26955-26965.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.